85 related articles for article (PubMed ID: 28728518)
41. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
42. Three relapses after a haploidentical transplantation in a pediatric patient: Cure with no further transplantation.
Uygun V; Daloglu H; Öztürkmen S; Karasu G; Yesilipek A
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28703407
[TBL] [Abstract][Full Text] [Related]
43. Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
Sedlácek P; Trka J; Zuna J; Hrusák O; Honzátková-Krsková L; Stary J
Haematologica; 2000 Oct; 85(10):1100-2. PubMed ID: 11025608
[No Abstract] [Full Text] [Related]
44. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
[TBL] [Abstract][Full Text] [Related]
45. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
46. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
[TBL] [Abstract][Full Text] [Related]
47. [Variant fusion transcript in ALL children with E2A-PBX1 fusion gene positive].
Li ZG; Zhao W; Wu MY; Hu YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):516-20. PubMed ID: 16800933
[TBL] [Abstract][Full Text] [Related]
48. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
[TBL] [Abstract][Full Text] [Related]
49. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
50. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
Robinson HM; Broadfield ZJ; Cheung KL; Harewood L; Harris RL; Jalali GR; Martineau M; Moorman AV; Taylor KE; Richards S; Mitchell C; Harrison CJ
Leukemia; 2003 Nov; 17(11):2249-50. PubMed ID: 14523475
[No Abstract] [Full Text] [Related]
51. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
Hunger SP; Cleary ML
Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
[TBL] [Abstract][Full Text] [Related]
52. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
Holmlund T; Lindberg MJ; Grander D; Wallberg AE
Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
[TBL] [Abstract][Full Text] [Related]
53. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
[TBL] [Abstract][Full Text] [Related]
54. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
55. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
[TBL] [Abstract][Full Text] [Related]
56. Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin.
Lukes J; Potuckova E; Sramkova L; Stary J; Starkova J; Trka J; Votava F; Zuna J; Zaliova M
Genes Chromosomes Cancer; 2018 Sep; 57(9):471-477. PubMed ID: 29726059
[TBL] [Abstract][Full Text] [Related]
57. The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Ma X; Wu D; Sun A; Qiu H; Fu Z; Wu X; Chen S; Mohty M
Am J Hematol; 2010 Feb; 85(2):141-2. PubMed ID: 20029991
[No Abstract] [Full Text] [Related]
58. Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.
Willasch AM; Salzmann-Manrique E; Krenn T; Duerken M; Faber J; Opper J; Kreyenberg H; Bager R; Huenecke S; Cappel C; Bremm M; Pfirrmann V; Merker M; Ullrich E; Bakhtiar S; Rettinger E; Jarisch A; Soerensen J; Klingebiel TE; Bader P
Bone Marrow Transplant; 2017 Feb; 52(2):201-208. PubMed ID: 27643863
[TBL] [Abstract][Full Text] [Related]
59. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence.
Yang W; Treviño LR; Yang JJ; Scheet P; Pui CH; Evans WE; Relling MV
Leukemia; 2010 Apr; 24(4):894-6. PubMed ID: 20054350
[No Abstract] [Full Text] [Related]
60. Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match.
Gallanagh M; Shaw O; Kaur H; Raj K
Bone Marrow Transplant; 2019 Jun; 54(6):907-910. PubMed ID: 30390062
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
